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Abstract (208 words) 
PURPOSE To determine the approaches used in withdrawing mechanical ventilator support. 
MATERIALS and METHODS   Speakers from the invited faculty of the World Federation of Societies 
of Intensive and Critical Care Medicine Congress in 2013 with an interest in ethics were asked to 
provide a detailed description of individual approaches to the process of withdrawal of mechanical 
ventilation.  
RESULTS   Twenty one participants originating from 13 countries, responded to the questionnaire 
Four respondents indicated that they do not practice withdrawal of mechanical ventilation and another 
4 indicated that their approach is highly variable depending on the clinical scenario. Immediate 
withdrawal of ventilation was practiced by a large number of the respondents (7/16; 44%). A terminal 
wean is practiced by just over a third of the respondents [6/16; 38%].  Extubation is practiced in more 
than 70% of instances amongst the majority of the respondents [(9/17; 53%]. Two of the respondents 
[2/17; 12%] indicated that they would extubate all patients whilst 14 respondents indicated that they 
would not extubate all their patients.  The emphasis was on tailoring the approach utilised to suit 
individual case scenarios.  
CONCLUSIONS Withdrawing of ventilator support is not universal. However, even when withdrawing 
mechanical ventilation is acceptable, the approach to achieve this endpoint is highly variable and 
individualised.  
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1. Introduction 
The frequency of limitation of life sustaining-therapies (LST) has increased during the past two 
decades (1-3). Large scale studies demonstrate substantial variation in practice within and between 
regions and countries such that withdrawal of LST ranges from 0-96% (4-7). In many cases withdrawal 
of LST includes the withdrawal of mechanical ventilation. However the method of withdrawing a 
patient from mechanical ventilation varies widely and is influenced by intensive care unit (ICU) 
protocols, physician beliefs, the clinical scenario as well as patient and family preferences. Additionally 
cultural factors, religious background (of the physician and the family) as well as the regional legal 
framework also influence the approach that is utilized in withdrawing mechanical ventilation (8,9). As 
such, the “one size fits all” approach may not be utilized for the process of withdrawal of mechanical 
ventilation.  
 
The lack of uniformity of approaches and the need to consider several issues prior to removing a 
patient from mechanical ventilation has great clinical implications for patients and their families and 
clinicians. Moreover, with globalization and migration, cultural and religious norms are not confined to 
regions or by borders and clinicians should be aware of these differences. Thus, we engaged an 
international group of senior practitioners with an interest in this issue to ascertain their practices.  
These practices in withdrawing mechanical ventilation are discussed below.  
 
 
2. Methods During the 11
th
 Congress of the World Federation of Societies of Intensive and Critical 
Care Medicine (WFSICCM) which was held in August and September 2013 in Durban, South Africa an 
Ethics Round Table was convened as a component of the scientific program.  Prior to the meeting, 
speakers from the invited faculty list of the WFSICCM Congress with an interest in ethics were 
approached to participate in the Ethics Round Table. Round Table participants were asked to identify 
their three most pressing specific worldwide ethical issues that the group should address. The majority 
responded that they were interested in end-of-life issues including withholding and withdrawing life-
sustaining treatments. An iterative process among respondents was performed by email prior to the 
conference in order to choose the most pertinent questions relating to these items for further work and 
discussion at the Congress. Initially 70 questions related to withholding and withdrawal of LSTs were 
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sent to participants. The interactive process resulted in the identification of 16 relevant topics that were 
felt to warrant further exploration. Respondents were then asked to identify the most important topics 
for further discussion at the Congress. The five topics with the greatest differences between centers 
and countries were chosen. They included questions related to age as a factor to determine 
withholding and withdrawing life-sustaining treatments at the end of life, health care professional end-
of-life decision making, patient/family end-of-life decision making, how to withdraw mechanical 
ventilation and differences between withholding and withdrawing life-sustaining treatments. Prior to the 
World Congress meeting, potential questions for the five topics were distributed via email to the 
experts. At the meeting and during several weeks after the meeting, 76 questions were finalized using 
a Likert scale (strongly agree, agree, neutral, disagree and strongly disagree), which all round table 
participants answered.  Following the meeting specific questions pertaining to mechanical ventilation 
were developed and distributed to 22 participants from 13 countries.  This manuscript concentrates 
on:  a detailed description of individual approaches to the process of withdrawal of mechanical 
ventilation, terminal weaning (including timelines), terminal extubation, sequence of withdrawal of 
mechanical ventilation and the practice of extubation. 
 
3. Results 
Twenty one participants responded to the questionnaire. The respondents originate from 13 countries. 
Table 1 summarises the approach of the respondents who practice withdrawal of mechanical 
ventilation. Four respondents indicated that they do not practice withdrawal of mechanical ventilation. 
They were practitioners from Israel, China, South Korea and Saudi Arabia. Four respondents, each 
from a different country (Canada, South Africa, USA and Europe) indicated that their approach to 
ventilation withdrawal is highly variable depending on the clinical scenario. Immediate withdrawal of 
ventilation is practiced by some of the respondents (7/16; 44%). A terminal wean is practiced by just 
over a third of the respondents [6/16; 38%]. Amongst the respondents who practice a terminal wean, a 
third conducted this over a period of less than 30 minutes. Two of the respondents [2/17; 12%] 
indicated that they would extubate all patients whilst 14 respondents indicated that they would not 
extubate all their patients.  Extubation was practiced in ≥ 70% of instances amongst the majority of the 
respondents [(9/17; 53%]. The extubation rate in this group of respondents ranged from <5% to 95 % 
of patients. One respondent from South Africa did not extubate any patient. This practice was 
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attributed to family request- none of the families agreed to extubation. The practice of extubation 
varies within and between regions (Table 2). Apart from the emphasis on appropriate analgo-sedation, 
it is clear that the precise steps involving the withdrawal of mechanical ventilation are highly variable. 
Despite the same end-point, the sequence, adjustments and targets for reducing FiO2, PEEP and tidal 
volume differed amongst all the respondents. The major emphasis was on tailoring the approach to 
suit individual case scenarios.  
 
4.  Discussion  
There was considerable variation in the manner of mechanical ventilation withdrawal not only between 
the respondents but respondents varied their individual approach depending on the clinical scenario. 
This practice variation is supported by a previous report outlining that the manner of mechanical 
ventilation withdrawal differs amongst intensivists (10). The sequence of events is dependent on a 
multitude of factors which includes the legal framework, cultural factors, religious background, 
physician’s perspective and the family’s wishes. Hence, it is evident that the withdrawal of mechanical 
ventilation cannot be addressed in a didactic checklist manner.  Nonetheless there are specific issues 
that warrant consideration when finalising the individualised approach that will be utilised for the 
withdrawal of mechanical ventilation. These issues include the influence of the legal framework, the 
components of a family meeting, the precise approach to withdraw mechanical ventilation, symptom 
management, the approach to the debriefing process and the need for documentation. These 
concepts are discussed in the context of the available evidence below.  
 
4.1 Influence of legal framework. 
Health care practices are essentially informed and molded by the health care legislation of the 
respective countries.  For example, withdrawal of continuous LST is not permitted in Israel in 
accordance with halacha or Jewish religious law and an Israeli statute (11). Withdrawal of mechanical 
ventilation is not practiced in Israel and Saudi Arabia. In China there is no local or national legislation 
that governs the withdrawal of life-sustaining treatments, although it is practiced by sending patients 
“home to die” or as requested by families because of financial constraints (12). The Round table 
responses indicate that withdrawal of mechanical ventilation is practiced in the United States, 
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Germany, Belgium, France, the Netherlands, Australia, New Zealand, Canada, South Africa and Hong 
Kong. 
 
 The legal framework governing the practice of withholding/withdrawing in various countries is 
expanded upon elsewhere (13).   
 
4.2 Family meeting 
The family usually feels helpless and filled with mixed emotions prior to the withdrawal of mechanical 
ventilation and hence a formal meeting to allay their fears, to guide them appropriately and to address 
their questions is crucial at an early stage.  It is essential that the family be assured from the outset 
and be made aware that the caregivers are committed to achieving what is best for the patient and 
family without causing any needless suffering. This will pave the way for appropriate decision making 
and resource allocation. The family also needs to be aware that the timing of death cannot be 
predicted with certainty and that following the withdrawal of mechanical ventilation the dying process 
may extend from minutes to hours or even several days (14).  This projects honesty and draws the 
family closer to the caregivers. The family will be more likely to be understanding of midcourse 
treatment failures and also more accepting  of alternative management plans  should they need to be 
considered in the future. If the family requests to be present during the withdrawal procedure they 
need to be counselled explicitly as to what to expect. Additionally there needs to be a strong support 
structure for families, because family members present at the time of death report higher symptoms of 
posttraumatic stress disorder (15). The aforementioned issues and the specifics related to the timing, 
location, the withdrawal process and the subsequent aftercare need to be addressed at the family 
meeting(s). These issues are listed in Table 3 and need to be considered within the context of 
withdrawal of other LSTs. This should be formally documented in the medical record before the actual 
withdrawal takes place. A limitation of this paper is that we did not explore the effect of patient and 
family wishes upon individual physician decision making processes. 
 
4.3 Withdrawal of mechanical ventilation: Terminal wean or Immediate withdrawal? 
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Mechanical ventilation may be withdrawn gradually (terminal wean) or immediately.  Whilst many 
critical care specialists favour one approach over the other it is not uncommon to individualise one’s 
approach based on the level of consciousness and the nature and extent of organ dysfunction. 
 
A terminal wean was first described by Grenvik (16). In all instances it is achieved over a variable time 
period (minutes to several hours generally, but may also be over a few days) as it depends on the rate 
of withdrawal by the physician. Table 4 lists the components that need to be considered in a terminal 
wean. 
 
The rationale to reduce PEEP is based on the assumption that the resultant atelectasis will worsen 
V/Q mismatch and accelerate hypoxia which may be advantageous. The concern that the removal of 
PEEP may worsen secretions may be obviated with the administration of anticholinergic agents if 
deemed necessary.  
 
Endpoints are achieved at different rates depending on the clinician’s and family’s preferences and are 
not evidence based. The rate and manner of withdrawal may need to be further individualised in 
accordance to the symptoms experienced by the patient. The time period to achieve the above may 
be short (< 30 minutes) or longer (few hours to several hours) and depends on the clinical scenario as 
well as the patient’s symptoms. Depending on the pace of withdrawal, anticipatory sedation needs to 
be administered when indicated. Sedation increments need to be supported by the presence of 
distress or discomfort. For each patient the medical and nursing team need to engage in discussions 
and agree on the method of achieving adequate patient comfort without intentionally hastening or 
prolonging the dying process. 
 
A terminal wean potentially confers the following advantages:   
- Upper airway obstruction signs- such as stridor, excessive secretions, coughing- are not 
encountered. 
- As the changes are made over a period of time analgo-sedation titration is achieved more easily. 
Thus symptoms such as dyspnoea are less likely compared to a terminal extubation. 
- If the family is present the lack of signs of patient discomfort is reassuring and comforting. 
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- The family may prefer a gradual withdrawal of LST compared to an abrupt cessation of LST.  
- The family may also prefer this method as it permits them more time (than immediate withdrawal) 
to interact with the patient during his/her last moments (eg hold the patient’s hand or carry a child 
in their arms, without the hindrance of multiple devices)   
- The staff is also not exposed to the symptoms of patient discomfort. 
 
Disadvantages associated with a terminal wean may include the following: 
- The process may take longer.  
- The family spends more time with the patient and there is a possibility of them becoming 
distressed or reconsidering their decisions to withdraw therapy. 
- The longer duration compared to immediate withdrawal is associated with a greater use of human 
and other expensive resources. 
 
Immediate withdrawal of mechanical ventilation may be achieved by either: 
(i) Manual disconnection of the mechanical ventilator (with or without transitioning to a T-piece) or  
(ii) Terminal extubation (removal of the airway without reducing ventilation support). 
 
Immediate withdrawal of mechanical ventilation requires adequate anticipatory sedation (unless the 
patient is dead or neurologically unresponsive) prior to the abrupt termination of all ventilator support.  
The principle advantages of this approach are: 
- There is no undue prolongation of the withdrawal process where the institution of LST is 
considered to be futile. The process of undue suffering (for the patient, family and staff) is thus 
not prolonged. 
- Removing the endotracheal tube is in keeping with the decision to remove all LST.  
- It may be particularly welcome if the endotracheal tube has been a source of discomfort to the 
patient. 
- In children, families may prefer seeing the child’s face without tubes and tapes. 
- The family and staff are not subjected to a prolonged weaning process. 
- Effective management of resources. Terminal weaning over several hours may deprive another 
patient ICU care. In the current era of cost containment and lack of ICU beds it would make 
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sense to consider terminal extubation once therapy is considered to be futile. It is however 
imperative that a terminal extubation not be considered as an afterthought when there is a 
sudden need for an ICU bed. The initial decision on the approach to withdrawal needs to be 
followed as a deviation from the initial plan places undue pressure on the health care providers 
and the family.   
 
Dyspnoea (if inadequately sedated), post extubation stridor and copious secretions are the main 
disadvantages of a terminal extubation. The excessive secretions in the upper airways can result in 
noisy respiration (death rattle). If the family is planning to be present they need to be prepared for the 
possibility of severe coughing, impression of the patient choking and excessive secretions.  
Discussions with the family should be utilised to   prepare them to expect such scenarios and to gauge 
the necessity for symptomatic treatment of the patient in order to reduce family anxiety.  As all 
decisions should focus around the care and needs of the patient the aim of the discussions should be 
directed towards preparedness for the process and allaying family anxiety.  Although it is controversial 
whether it is appropriate to give medications to a patient only for the purpose of relieving anxiety or 
distress of the family there are countries and cultures where there is also an obligation to care of the 
ICU patient’s families (11). When medications are considered to be required the family should be 
made aware that the medications are not indicated therapeutically but rather being used to reduce 
family anxiety or distress to family needs. Therapeutic strategies that may need to be considered 
include the follows; 
- Administration of steroids (100mg methylprednisone 6 hours and 30 minutes before extubation) 
to prevent post extubation stridor. For children an appropriate regimen would be dexamethasone 
0.6mg/kg IV followed by prednisolone 1mg/kg every 8 hours for a 24 hour period 
- Nebulised adrenaline post extubation to reduce stridor 
- Administration of anticholinergic agents to reduce the quantity of secretions (30 minutes before 
extubation: 20 mg Butylscopolamine IV, or 0,4 mg Hyoscine hydrobromide) (17) 
- Diuretics in the hypervolemic patient, to reduce the amount of brocho-pulmonary secretions. 
- Suctioning to remove excessive secretions. This should be done before extubation (18) 
- Positioning the patient such that airflow is not impeded 
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- If the patient demonstrates signs of discomfort the analgo sedative dosing needs to be adjusted 
to ensure patient comfort before proceeding with the withdrawal of the mechanical ventilation. 
 - Administration of humidified air post extubation to prevent drying of the airway passages 
 
It is debatable as to which of these methods is superior and it has been suggested that the 
patient’s/family’s preferences be factored in the decision making process (19). The level of 
consciousness of the patient is also an important determinant. Patients who are “awake” are more 
likely to experience distress and as such a terminal wean is probably better suited than immediate 
withdrawal of mechanical ventilation.  On the other hand, in a neurologically unresponsive or 
unconscious patient, immediate withdrawal of mechanical ventilation might be better suited than a 
terminal wean. It has been observed that the terminal wean is preferred by anaesthesiologists whilst a 
terminal extubation is preferred by paediatricians and physicians (10). It has also been demonstrated 
that most clinicians tend to utilise several strategies rather than just one method (10, 20).   
 
 
4.4 Management of symptoms 
Depending on the precise manner of withdrawal of mechanical ventilation the patient may experience 
pain, anxiety, delirium, respiratory distress, dyspnoea, vomiting, excessive broncho-pulmonary 
secretions and post extubation stridor. It is the physician’s medical and ethical responsibility to ensure 
these issues are prevented and appropriately managed. 
 
4.4.1. Pain and anxiety (anticipatory dosing vs terminal sedation)- The amount and type of analgo- 
sedation prescribed is largely influenced by judging the patient’s capability of experiencing pain and 
discomfort prior to withdrawal of mechanical ventilation. Where it is difficult to predict the requisite 
dose, it is preferable to adopt a more liberal dosing strategy rather than to risk under dosing and lead 
to patient discomfort and pain. On one end of the spectrum the comatose patient requires no analgo- 
sedation whilst the patient who is fully conscious or anxious represents the other extreme where the 
anticipatory analgo-sedation warrants consideration. Once analgo-sedation is initiated the patient’s 
clinical response needs to be carefully monitored to ensure that the patient is experiencing no pain or 
discomfort. It is only then that mechanical ventilation may be withdrawn- with on-going assessment 
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and adjustment of the analgo-sedative agent(s). Anticipatory analgo-sedation is preferred to the 
practice of increasing the doses in response to observed pain or discomfort (reactionary dosing) as it 
prevents The deliriogenic potential of benzodiazepines and opioids  is probably irrelevant as in the 
vast majority the time to death is not protracted. If a prolonged wean is anticipated then the risk of 
delirium may be reduced by avoiding the use of both deliriogenic agents and physical restraints. 
unnecessary suffering of the patients and distress of the family. Opioids, benzodiazepines and 
propofol are most commonly employed for this purpose.  An opioid- benzodiazepine combination has 
been traditionally useful in that the opioid addresses pain, dyspnoea and coughing whilst the 
benzodiazepine relieves anxiety and discomfort. An added advantage of benzodiazepines is their anti-
convulsive properties in patients who develop seizures secondary to hypoxemia.  Opioids can be 
hallucinogenic. The choice of analgo-sedatives and the factors influencing this has been extensively 
reviewed by the SCCM Ethics Committee (21). There is no maximum dose for the prescribed agents. 
Reports of documented rates indicate that morphine dosages vary widely and range from 0-85 mg/hr 
(10,22,23). The dose needed will be influenced by previous exposure to the agent(s) and should be 
titrated at 15 minute intervals. To ensure adequate analgesia additional boluses of morphine in 
addition to increasing the morphine infusion dose may be necessary. Suggested regimens are 
summarised in Table 5. 
 
Clinicians are sometimes uncomfortable with the concept of anticipatory sedation and hence hesitant 
to prescribe it as they fear that this practice may hasten the patient’s death. The use of analgo-
sedatives (which have the potential to hasten death) is commonly justified by the doctrine of double 
effect - an action which on the one hand promotes good due to a good intention, but also 
simultaneously causes unintentional serious harm. This principle is used to justify the use of analgo-
sedatives so long as they address pain and discomfort and are not being used with the intention of 
hastening death. The relief of pain and discomfort is considered to be important enough to permit its 
use and although it may unintentionally result in a hastened death, the use of sedatives under these 
circumstances is ethically sound. However, while the potential exists, the use of sedatives has not 
been demonstrated to significantly hasten death (24-27).   
In fact the reality is that the patient’s actual cause of death (the underlying organ dysfunction or 
disease) always remains unchanged.  The time to death is also influenced by a multitude of other 
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factors including the combined decisions made by the physician, family and nurses on how to 
withdraw therapy. Once the decision to withdraw LST is made it is essential that there is detailed 
documentation relating to the clinical assessment, agents prescribed and the doses used and reasons 
for dose adjustments. Such documentation will clarify the reason(s) for anticipatory sedative use.   
 
 
4.4.2. Dyspnoea or abnormal breathing patterns 
Dyspnoea constitutes a commonly observed phenomenon. Treatable causes of dyspnoea need to be 
sought and addressed. This may include the use of opioids, sedatives, bronchodilators or even 
diuretics. With terminal weaning the pattern of breathing changes in that the breaths are less frequent, 
and are shallow and erratic. The family needs to be aware of this so that they do not get unduly 
distressed.  It is recommended that sedatives be prescribed to keep the respiratory rate below 28 
breaths/minute (22). Additionally sedatives should be initiated or increased if patients demonstrate 
further signs of respiratory distress or if the respiratory rate doubles.  Occasionally the patient may 
choose that he/she remains lucid during the process, rather than be sedated (to mask symptoms) and 
this needs to be respected so long as there is no undue suffering of the patient.  
 
4.4.3 Nausea and Vomiting 
Nausea and vomiting are frequent symptoms, which may necessitate the use of anti-emetic agents or 
nasogastric tube drainage (28). 
 
4.4.4 Neuromuscular blockade 
These agents do not provide analgesia or sedation. They need to be stopped if previously prescribed 
and ideally one should wait until they have been cleared from the system. This may be judged by the 
return of respiratory efforts. On rare occasions this may not be possible and if it is in the best interest 
of the patient to have a terminal extubation without delay, then adequate anticipatory analgo-sedation 
needs to be meticulously ensured. Neuromuscular blockade has no role in end-of–life care and should 
never be initiated as part of the terminal weaning or terminal extubation process.  
 
4.5 Documentation  
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Documentation should include discussions, decisions, timelines and outcome of actions.  
Important items to document pertaining to the withdrawal of mechanical ventilation include: 
- Reason(s) for withdrawal 
- Decision making- individuals involved(including family members) 
- Chairperson for discussions 
- Consensus reached regarding procedure to be followed 
- Specific requests 
- Family support 
- Debriefing sessions  
 
4.6 Debriefing 
Health care workers are trained to save lives rather than be involved in withholding or withdrawing 
LST. Thus, even though withdrawal of mechanical ventilation is in the interest of the patient, the ICU 
team may still experience distress, anxiety and grief. As such a formal debriefing meeting, scheduled 
a few days after the event, should be performed.  The goal is to alleviate caregiver burnout by 
providing adequate emotional support in an atmosphere that is conducive of trust and mutual 
understanding of different opinions. Ideally it should be moderated by a professional who is acceptable 
to everyone and is not involved in the withdrawal process. Items to address include: 
- Why was treatment withdrawn 
- Specific approach agreed upon 
- Specific family requests 
- Feedback from  all involved 
- Feelings/Emotions of the individuals involved 
- The need for and provision of personal space- for individuals who may need this 
- The provision of skills to deal with the issues that may arise 
- Summary and future plans 
Whilst the lack of resources may preclude the implementation of a comprehensive debriefing process, 
the vast majority of these objectives may be achieved with an in-house debriefings program. 
Debriefing sessions may be moderated by the head of the unit together with the nursing manager. 
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Individuals identified to require additional assistance may then be referred for appropriate assistance if 
necessary.  
 
3. Conclusions 
Whilst the end point of withdrawing mechanical ventilation is unambiguous, the approach to achieve 
this endpoint remains highly variable (within and between countries) and needs to be individualised. A 
single approach therefore cannot be applied to all patients. The clinical scenario, patient/family 
preferences, clinician’s opinion as well as the legal framework of the country need to be considered in 
deciding the manner in which mechanical ventilation is withdrawn, if at all.  
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Table 1: Approach to withdrawal of mechanical ventilation 
 Response 
(n=17) 
Immediate withdrawal 7 
Terminal wean: 
- <30minutes 
- >30minutes 
 
2 
4 
Practice variable  4 
 
 
 
 
 
 
Table 2: Percentage of cases extubated during withdrawal of LST 
Countries  
Number of 
Participants Range (%) Mean (%) 
North America and Canada 6 21-100 69.2 
Europe 5 <5%-80 52.5 
South Africa 4 0-95 50 
Australia  1 - 70 
Hong Kong 1 - 20 
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Table 3: Issues to be discussed at the Family Meeting 
1. General 
- Withdrawal of LSTs is individualised in relation to patient’s wishes, patient’s culture and clinical 
condition.  
- Approach is also considered within the context of the laws that govern the region/country. 
- Recommendations and decisions are influenced by observations previous experiences related to 
the withdrawal of LSTs- a relatively new practice in that it is less than 50 years since it was first 
introduced in the ICU setting. 
-  The clinical diagnosis, prognosis and the logic  to support the withdrawal of LSTs 
- The use of additional aids (previous experience or images of anatomic damage) to assist in 
informing the decision to withdraw LSTs to be considered.  
2. Confirm who will represent the patient? 
- This needs to be considered  in the context of the countries’ legal framework regarding the legal 
standing of family members and identification of surrogate decision makers 
3. Assurance and Reassurance 
- From the outset it must be made obvious that the caregivers are totally committed to do what is in 
the best interest of the patient and the family unit. 
- Whilst there has been a shift in focus from providing  life preserving treatment to the avoidance of 
prolonging death, respect and care of the patient will continue until the end. 
4. Family conflicts 
- Support the family whilst they imbibe the implications of withdrawing LSTs and  deal with  the 
internal conflicts in an attempt  to reach a  near unanimous decision 
5. Timing and location of withdrawal of mechanical ventilation 
- Possibility of home as location 
- Location within the ICU (possibility of a private cubicle) 
- Transfer to palliative care area prior to extubation 
6. Specifics  to be performed prior to and/or after withdrawal  
-     Bathing 
-     Rituals 
-     Prayers 
7. Clinical team members that will be present. 
8. Would the family like to be present during the withdrawal procedure? 
- How will young children be managed? 
- Presence of non- family members 
- Does the family want a psychologist or clergy to be present? 
9. Procedure of withdrawal 
- Determine the specific approach to be used 
(i) Terminal weaning (discuss what will be withdrawn, precise steps and duration) or  
(ii) Immediate withdrawal of mechanical ventilation with  
                    - Manual disconnection of the ventilator or 
                    - Extubation (terminal extubation) 
- Symptom  management (breathlessness ,death rattle, pain, secretions, vomiting) 
- Reducing discomfort (environment, alarms, investigations) 
- Unexpected events  and how some may be avoided  
10. Potential outcomes including variable response to withdrawal – discuss that time to death is usually 
unpredictable (and that the patient may not die immediately and   alternative future plans need to be 
made). 
11. Procedure after death (where is the body taken to, undertaker, documentation) 
12. Family notification process. If the family chooses to be absent during the withdrawal process or if the 
process is being conducted over a lengthy period then there needs to be a plan regarding death 
notification. 
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Table 4: Terminal weaning process 
1. Ensure appropriate environment 
2. Ensure adequate sedation and pain relief (analgo-sedation) 
3. Deactivate alarms 
4. Reduce FiO2 to 0.21 (0-5minutes) 
5. Reduce PEEP to 0cm H2O (0-5minutes) 
6. Reduce pressure support to ≤5 cm H2O or tidal volume to 0ml - Reduce ventilator respiratory rate 
to zero (15minutes) 
7. Monitor for need to adjust analgo-sedation. Although reactive dosing is best avoided, one may 
need to increase ventilator support for a short duration in order to ensure patient comfort whilst 
titrating the analgo-sedative agents. 
8. Some patients will have died by this point where the patient is no longer receiving any positive 
pressure ventilatory support (ventilator rate and pressure support rate is 0). If not the mechanical 
ventilator is disconnected and the patient is extubated. 
If extubation is not planned then the options include 
 Use of CPAP  
 Connection to a T-piece 
 Continue to asses for signs of respiratory distress, discomfort, pain and anxiety and address 
accordingly 
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Table 5: Analgo-sedation (adult  70 kg patient) 
 Initial IV loading dose Initial Infusion rate Dose Increment 
Morphine 2-10 mg 0.05-0.1mg/kg/hour 25% 
Fentanyl 0.5-2mcg/kg/hour 1-5 mcg/kg/hour 25% 
Midazolam 1-2mg 1-5 mg/hour 25% 
Propofol 1mg/kg 0.5 -3mg/kg/hour 25% 
 
 
